KRAS and cancer: Studies have shown that under nutrient-sufficient conditions, the proliferation of some KRAS-mutant cancer cell lines is not strongly affected, or is relatively little affected, by pharmacological inhibition of autophagy, RNAi-mediated acute ATG5/ATG7 knockdown, or CRISPR-mediated ATG7 knockdown [237,238].